U.S. markets closed

Aziyo Biologics, Inc. (AZYO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.41-0.58 (-3.87%)
At close: 4:00PM EST

Aziyo Biologics, Inc.

12510 Prosperity Drive
Suite 370
Silver Spring, MD 20904
United States
240 247 1147

IndustryMedical Devices
Full Time Employees156

Key Executives

NameTitlePayExercisedYear Born
Mr. Ronald K. LloydCEO, Pres & Director676.25kN/A1961
Dr. Darryl Roberts Ph.D.Exec. VP of Operations & Product Devel.382.75kN/A1961
Mr. Thomas EngleseChief Commercial Officer451.11kN/A1974
Mr. Kevin L. Rakin M.B.A, M.S.Exec. ChairmanN/AN/A1961
Mr. Jeffry D. HametVP of Fin.N/AN/AN/A
Mr. Matthew B. FergusonChief Financial OfficerN/AN/A1968
Ms. Courtney GuyerVP of MarketingN/AN/AN/A
Dr. Jerome Riebman FACC, M.A., M.D.Chief Medical OfficerN/AN/A1954
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. It has additional offices in Roswell, Georgia; and Richmond, California

Corporate Governance

Aziyo Biologics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.